Cargando…
Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review
The purpose of this systematic review is to evaluate the efficacy and safety of using potential drugs: remdesivir and glucocorticoid in treating children and adolescents with COVID-19 and intravenous immunoglobulin (IVIG) in treating MIS-C. We searched seven databases, three preprint platform, Clini...
Autores principales: | Wang, Zijun, Zhao, Siya, Tang, Yuyi, Wang, Zhili, Shi, Qianling, Dang, Xiangyang, Gan, Lidan, Peng, Shuai, Li, Weiguo, Zhou, Qi, Li, Qinyuan, Mafiana, Joy James, Cortés, Rafael González, Luo, Zhengxiu, Liu, Enmei, Chen, Yaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861482/ https://www.ncbi.nlm.nih.gov/pubmed/35192051 http://dx.doi.org/10.1007/s00431-022-04388-w |
Ejemplares similares
-
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis
por: Zhou, Qi, et al.
Publicado: (2022) -
Guidelines for the Management of Children and Adolescent with COVID-19: protocol for an update
por: Zhou, Qi, et al.
Publicado: (2021) -
Quality and consistency of clinical practice guidelines for treating children with COVID-19
por: Li, Qinyuan, et al.
Publicado: (2021) -
Risk factors for poor prognosis in children and adolescents with COVID-19: A systematic review and meta-analysis
por: Shi, Qianling, et al.
Publicado: (2021) -
Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis
por: Lu, Shuya, et al.
Publicado: (2020)